Total Holdings
54
As of Oct 4, 2026
Invesco Dorsey Wright Healthcare Momentum ETF
PTHNASDAQInvescoEquity
$55.89Today:- (-)1Y +26.35%
As of Oct 16, 2026 close
- Assets (AUM)
- $299.39M
- Expense ratio
- 0.60%
- Dividend yield
- 2.63%
- Holdings
- 54
- 52-week range
- $45.45$64.10
- Volume (live)
- -
- Avg. volume (3M)
- 37.43K
PTH ETF Holdings: Invesco Dorsey Wright Healthcare Momentum ETF
Every listed position with its portfolio weight, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Top 10 Holdings
44.7%
Share of fund assets
Assets (AUM)
$299.39M
Total fund assets
Expense Ratio
0.60%
Annual management fee
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
All 61 PTH Holdings by Portfolio Weight
Holdings as of Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position.
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Roivant Sciences Ltd | Stock | 5.68% |
| 2 |  | Revolution Medicines, Inc | Stock | 5.12% |
| 3 |  | Iovance Biotherapeutics, Inc. | Stock | 4.80% |
| 4 |  | Moderna, Inc | Stock | 4.75% |
| 5 |  | Guardant Health, Inc | Stock | 4.61% |
| 6 |  | 10x Genomics, Inc. | Stock | 4.53% |
| 7 |  | Axsome Therapeutics, Inc | Stock | 3.98% |
| 8 |  | Natera, Inc. | Stock | 3.78% |
| 9 |  | BrightSpring Health Services Inc. Common Stock | Stock | 3.78% |
| 10 |  | Twist Bioscience Corporation | Stock | 3.68% |
| 11 |  | Tenet Healthcare Corporation | Stock | 3.56% |
| 12 |  | Insmed Incorporated | Stock | 3.49% |
| 13 |  | Medpace Holdings, Inc. | Stock | 2.67% |
| 14 |  | Oruka Therapeutics, Inc. | Stock | 2.50% |
| 15 |  | Erasca Inc | Stock | 2.45% |
| 16 |  | Illumina, Inc. | Stock | 2.45% |
| 17 |  | Travere Therapeutics Inc | Stock | 2.44% |
| 18 |  | Hinge Health, Inc. | Stock | 2.35% |
| 19 |  | Exelixis, Inc. | Stock | 2.32% |
| 20 |  | Liquidia Corporation | Stock | 2.28% |
| 21 |  | Protagonist Therapeutics, Inc. | Stock | 2.25% |
| 22 |  | Relay Therapeutics, Inc. | Stock | 2.23% |
| 23 |  | Halozyme Therapeutics, Inc. | Stock | 2.20% |
| 24 |  | Replimune Group Inc | Stock | 2.12% |
| 25 |  | Oscar Health Inc | Stock | 2.10% |
| 26 |  | CareDx, Inc. | Stock | 2.09% |
| 27 |  | Axogen, Inc. | Stock | 2.02% |
| 28 |  | Charles River Laboratories International, Inc. | Stock | 1.99% |
| 29 |  | MBX Biosciences, Inc. | Stock | 1.98% |
| 30 |  | PACS Group, Inc. | Stock | 1.94% |
| 31 |  | agilon health Inc | Stock | 1.93% |
| 32 |  | Humana Inc | Stock | 1.91% |
| 33 |  | Arrowhead Pharmaceuticals, Inc | Stock | 1.88% |
| 34 |  | Dianthus Therapeutics, Inc. | Stock | 1.87% |
| 35 |  | Centene Corporation | Stock | 1.82% |
| 36 |  | Jazz Pharmaceuticals plc | Stock | 1.79% |
| 37 |  | Spyre Therapeutics Inc. | Stock | 1.77% |
| 38 |  | Cytokinetics, Incorporated | Stock | 1.72% |
| 39 |  | Kymera Therapeutics, Inc. | Stock | 1.68% |
| 40 |  | Ligand Pharmaceuticals Incorporated | Stock | 1.65% |
| 41 |  | Viatris Inc | Stock | 1.63% |
| 42 |  | Corcept Therapeutics Incorporated | Stock | 1.61% |
| 43 |  | Enliven Therapeutics Inc. | Stock | 1.60% |
| 44 |  | Hims & Hers Health, Inc | Stock | 1.49% |
| 45 |  | uniQure N.V | Stock | 1.46% |
| 46 |  | Arcutis Biotherapeutics, Inc | Stock | 1.30% |
| 47 |  | NeoGenomics, Inc | Stock | 1.16% |
| 48 |  | Krystal Biotech, Inc | Stock | 1.13% |
| 49 |  | Establishment Labs Holdings Inc | Stock | 1.10% |
| 50 | NYSE MKT:NHC | National HealthCare Corporation | Stock | 1.05% |
| 51 |  | TG Therapeutics, Inc | Stock | 1.04% |
| 52 |  | Absci Corp | Stock | 1.00% |
| 53 |  | Amneal Pharmaceuticals, Inc | Stock | 0.99% |
| 54 |  | Alkermes plc | Stock | 0.98% |
| 55 |  | Nuvation Bio Inc | Stock | 0.97% |
| 56 |  | Trevi Therapeutics Inc | Stock | 0.97% |
| 57 |  | Veracyte, Inc | Stock | 0.92% |
| 58 |  | Denali Therapeutics Inc | Stock | 0.85% |
| 59 |  | Guardian Pharmacy Services, Inc. | Stock | 0.84% |
| 60 |  | Clover Health Investments, Corp | Stock | 0.80% |
| 61 | KMPH | KemPharm Inc | Stock | 0.78% |
Source: Fund holdings disclosures. Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About Invesco Dorsey Wright Healthcare Momentum ETF Holdings
What are the top holdings in PTH?
As of Oct 4, 2026, Invesco Dorsey Wright Healthcare Momentum ETF (PTH) holds 54 securities. The largest are Roivant Sciences Ltd (5.68%), Revolution Medicines, Inc (5.12%), Iovance Biotherapeutics, Inc. (4.80%). The holdings table lists each position by portfolio weight with its ticker, name and asset type.
How concentrated is PTH's portfolio?
As of Oct 4, 2026, the 10 largest positions make up 44.7% of PTH's assets. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly.
What is PTH's sector allocation?
The Sector Allocation chart shows how PTH distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does PTH invest in?
PTH's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is PTH ETF?
PTH's diversification can be assessed by reviewing its 54 holdings (as of Oct 4, 2026), sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.